Comparison of the effects of acute changes in the circulating plasma glucose concentration on rates of glucose production (GP) in non-diabetic and diabetic individuals. Increase hepatic glucose production is the major cause of postabsorptive hyperglycemia (high blood sugar) in diabetes mellitis. Insulin maintains glucose homeostasis (stability in normal body states) by its principal actions of stimulation of glucose uptake in skeletal muscle and supression of GP. The study aim is to determine whether and how hyperglycemia alters hepatic glucose fluxes in non-diabetic and DM (diabetes mellitis) individuals in the presence of 'pancreatic clamp' conditions. Rates of GP and glucose cycling will be measured during somatostatin infusion and basal hormone replacement in the presence of normoglycemia and in response to standard increases in plasma glucose concentration. The potential role of hepatic glucokinase (a catalytic enzyme specific for glucose) in glucose induced inhibition of GP. There will be three study groups of 14 subjects, two with diabetes mellitis and one with normal glucose tolerance, matched for age, sex, body mass to the DM groups. All subjects will be 35-70 years old, in otherwise good health, not participating in any other study. Screening will include history, physical examination, hematologic, lipid, and chemistry, and consent procedures. Medications will be discontinued several hours prior to the study. All participants will be consuming a weight-maintaining diet containing at least 250 grams of carbohydrates per day for several days before the study. DM patients will be admitted and insulin will be infused by vein and continued overnight. Control patients will be admitted on the day of the study for an overnight fast. Both control and DM patients will be studied after fasting. Two tubes will be inserted, one for infusion, the other for blood sampling. During the study, several infusions of insulin and fructose and blood tests will be done. Indirect calorimetry will be done.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
General Clinical Research Centers Program (M01)
Project #
5M01RR000065-38
Application #
6419299
Study Section
National Center for Research Resources Initial Review Group (RIRG)
Project Start
1977-12-01
Project End
2002-11-30
Budget Start
Budget End
Support Year
38
Fiscal Year
2000
Total Cost
Indirect Cost
Name
Virginia Commonwealth University
Department
Type
DUNS #
City
Richmond
State
VA
Country
United States
Zip Code
23298
Holkova, Beata; Yazbeck, Victor; Kmieciak, Maciej et al. (2017) A phase 1 study of bortezomib and romidepsin in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma, indolent B-cell lymphoma, peripheral T-cell lymphoma, or cutaneous T-cell lymphoma. Leuk Lymphoma 58:1349-1357
Corey, Kathleen E; Vuppalanchi, Raj; Vos, Miriam et al. (2015) Improvement in liver histology is associated with reduction in dyslipidemia in children with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr 60:360-7
Eaton, J E; Juran, B D; Atkinson, E J et al. (2015) A comprehensive assessment of environmental exposures among 1000 North American patients with primary sclerosing cholangitis, with and without inflammatory bowel disease. Aliment Pharmacol Ther 41:980-90
Worthington Jr, Everett L; Berry, Jack W; Hook, Joshua N et al. (2015) Forgiveness-reconciliation and communication-conflict-resolution interventions versus retested controls in early married couples. J Couns Psychol 62:14-27
Holkova, Beata; Kmieciak, Maciej; Perkins, E Brent et al. (2014) Phase I trial of bortezomib (PS-341; NSC 681239) and ""nonhybrid"" (bolus) infusion schedule of alvocidib (flavopiridol; NSC 649890) in patients with recurrent or refractory indolent B-cell neoplasms. Clin Cancer Res 20:5652-62
Lo, D J; Farris, A B; Song, M et al. (2013) Inhibition of ?v?6 promotes acute renal allograft rejection in nonhuman primates. Am J Transplant 13:3085-93
Jones, Robert; Vuky, Jacqueline; Elliott, Tony et al. (2013) Phase II study to assess the efficacy, safety and tolerability of the mitotic spindle kinesin inhibitor AZD4877 in patients with recurrent advanced urothelial cancer. Invest New Drugs 31:1001-7
Al Hawaj, M A; Martin, E J; Venitz, J et al. (2013) Monitoring rFVIII prophylaxis dosing using global haemostasis assays. Haemophilia 19:409-14
Noureddin, Mazen; Yates, Katherine P; Vaughn, Ivana A et al. (2013) Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients. Hepatology 58:1644-54
Lo, D J; Anderson, D J; Weaver, T A et al. (2013) Belatacept and sirolimus prolong nonhuman primate renal allograft survival without a requirement for memory T cell depletion. Am J Transplant 13:320-8

Showing the most recent 10 out of 367 publications